Page last updated: 2024-10-30

lansoprazole and Tachycardia, Ventricular

lansoprazole has been researched along with Tachycardia, Ventricular in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsubokura, M1
Miura, Y1
Itokawa, T1
Murata, K1
Takei, N1
Higaki, T1
Murashige, N1
Kami, M1
Komatsu, T1

Other Studies

1 other study available for lansoprazole and Tachycardia, Ventricular

ArticleYear
Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
    Journal of clinical pharmacology, 2011, Volume: 51, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antifungal Agents; Aspergillosis;

2011